Senti Biosciences Files 8-K
Ticker: SNTI · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1854270
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
TL;DR
Senti Bio filed an 8-K on 6/18/25. Check it for event details.
AI Summary
Senti Biosciences, Inc. filed an 8-K on June 18, 2025, to report an event under Regulation FD Disclosure and Other Events. The filing does not contain specific financial figures or significant operational updates beyond the reporting of the event itself.
Why It Matters
This 8-K filing indicates a material event has occurred for Senti Biosciences, Inc., requiring public disclosure. Investors should review the filing for details on the nature of the event.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting an event without immediate financial implications or significant operational changes detailed within the provided text.
Key Players & Entities
- Senti Biosciences, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of Report
- Regulation FD Disclosure (event) — Item Information
- Other Events (event) — Item Information
- 2 Corporate Drive, First Floor (location) — Principal Executive Offices Address
- South San Francisco, California 94080 (location) — Principal Executive Offices Address
FAQ
What specific event is Senti Biosciences, Inc. disclosing in this 8-K filing?
The provided text of the 8-K filing does not specify the exact nature of the event being disclosed, only that it falls under 'Regulation FD Disclosure' and 'Other Events'.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 18, 2025.
What is the principal executive office address for Senti Biosciences, Inc.?
The principal executive offices are located at 2 Corporate Drive, First Floor, South San Francisco, California 94080.
What is Senti Biosciences, Inc.'s IRS Employer Identification Number (EIN)?
Senti Biosciences, Inc.'s EIN is 86-2437900.
Under which sections of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Senti Biosciences, Inc. (SNTI).